Losartan Formulation

Organon & Co

Revision date : 2023-09-26

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08 GHS05 GHS07
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

232-674-9/9004-34-6

Name of the chemical

cellulose

Concentration

>=30-<50

EC/CAS

232-679-6/9005-25-8

Name of the chemical

Starch

Concentration

>=10-<20

General Information

Version

4.2

Revision date

2023-09-26

Product name

Losartan Formulation

1.2.1 Relevant identified uses

Pharmaceutical

Emergency telephone

+44 1 670 59 32 05, +1-215-631-6999

Icons in SDS

GHS05 GHS07 GHS08 M004 M009 M010 M011 M017

Company Information

company name

Organon & Co

e-mail address of the competent person responsible for the Safety Data Sheet

EHSSTEWARD@organon.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H302, H317, H318, H360D, H362, H373

Hazard statements

Code

Statements

H302

Harmful if swallowed

Section 2

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H302 Harmful if swallowed. H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H360D May damage the unborn child. H362 May cause harm to breast-fed children. H373 May cause damage to organs through prolonged or repeated exposure.

Prevention

P201 Obtain special instructions before use. P260 Do not breathe dust. P263 Avoid contact during pregnancy and while nursing. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.

Response

P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rins- ing. Immediately call a POISON CENTER/ doctor. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Hazardous Ingredients

Losartan

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means.

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) as amended by GB-CLP Regulation, UK SI 2019/720, and UK SI 2020/1567) Acute toxicity, Category 4 H302: Harmful if swallowed. Serious eye damage, Category 1 H318: Causes serious eye damage. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Reproductive toxicity, Category 1B H360D: May damage the unborn child. Effects on or via lactation H362: May cause harm to breast-fed children. Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.